entertainment -WSS

entertainment

author：Wikipedia 2025-09-28 20:22:51 - browse：3924

Immunofluorescence image shows CD4+ (green) and CD8+ (yellow) T cells in the microenvironment of a head and neck squamous cell carcinoma. — This immunofluorescence image shows T cells (in green and yellow) in the microenvironment of a head and neck squamous cell carcinoma. Allen Lab/NCI/NIH

Merus said Tuesday that the combination of its experimental drug petosemtamab with the checkpoint inhibitor Keytruda shrank tumors in 62% of patients with head and neck cancer, according to an interim analysis of an ongoing mid-stage clinical trial.

The new efficacy results, derived from a larger number of patients, look similar to an initial disclosure made last week that triggered a 36% increase in Merus’ stock price.

But the Dutch drugmaker on Tuesday withheld additional information from the study related to the safety and durability of petosemtamab’s tumor responses, pending presentation at the annual meeting of the American Society of Clinical Oncology on June 3.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： Wegovy, Zepbound and weight loss drugs that preserve muscle

WSS

PBM reforms clear House panel

American TikTok star stuck in Dubai for months following rental car altercation

Does good food count as health care? Study aims to find out

NYU radiologists take on the challenge of expensive MRI machines

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

leisure time

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

Drug repurposing or repositioning? The language matters

9 mass shootings over the weekend rock US cities, leaving 5 dead, 56 injured

Supreme Court strikes down use of affirmative action

Russian and Belarusian players banned from a women's tennis tournament in Prague

At least 13 dead in Texas as scorching temps continue

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

Guidelines to prevent youth baseball injuries need more muscle

Why medical students are struggling with mental health

BioMarin wins approval for gene therapy to treat hemophilia A

Ransomware attacks on hospitals: Study outlines patient impact

hotspot

Childhood cancer progress stalls for Black, Hispanic kids: Report

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

'Weather

Snowpack in the West is melting rapidly. Where will all that extra water go?

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

hotspot

Wikipedia

focus

leisure time